The I-GENE team is pleased to welcome you to the 8th issue of the I-GENE newsletter. I am proud to say that the team realized some major achievements during the last months.
We have optimized the chemistry of our nanoformulation in terms of
stability and ability to spontaneously cross the membranes of human melanoma cells to edit them. Our proprietary formulation has been patented on August 28 to protect the project IPR.
We have also launched the I-GeneMatcher software, please, try this free
Please, stay up to date on the I-GENE project by reading this and next project newsletters!